From: Pirfenidone improves survival in IPF: results from a real-life study
Patients data | UHH (n = 75) | RBH (n = 136) | P value |
---|---|---|---|
Age | 72.5 ± 7.6a | 62.5 ± 9.9a | P < 0.0001 |
Gender (male/female) | 64/11 | 96/40 | P < 0.01 |
Smoking status | |||
Never smokers | 26 | 27 | P = 0.08 |
Smokers | 49 | 109 | P = 0.34 |
Radiological pattern (Definite UIP/Possible UIP) | 41/34 | 56/55 | P = 0.7 |
Biopsy proven UIP | 9 | 25 | |
FEV1 | 87.4 ± 21.5a | 78.9 ± 15.6a | P < 0.0006 |
FVC | 81.8 ± 17.8a | 79.3 ± 18.0a | P = 0.16 |
DLco | 56.7 ± 16.0a | 46 ± 12.4a | P < 0.0001 |